Foghorn Therapeutics Inc. Company Contacts

Foghorn Therapeutics Inc.

http://www.foghorntx.com
Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic... Read More
Contacts

Country

United States

City

Cambridge

Headquarters

Cambridge, Massachusetts

Profile

Founded

2016

Industry

Biotechnology Research

Size

51 - 200

Funding

Total Rounds

3

Last Round

Sun May 19 2024

Last Round Series

Post IPO equity

Last Round Raised

$ 110,000,000